PEG-MGF

Quick Specifications

Research Overview

PEG-MGF (Pegylated Mechano Growth Factor) is a chemically modified version of MGF in which polyethylene glycol molecules are attached to the peptide structure through PEGylation. This single modification solves MGF's primary limitation — extending the half-life from 5-7 minutes to several hours or days, allowing twice-weekly rather than daily dosing and enabling the peptide to remain in circulation long enough to exert meaningful systemic effects. PEG-MGF works by activating muscle satellite cells — the stem-like progenitor cells responsible for muscle repair and hypertrophy — stimulating their proliferation and delaying premature differentiation, thereby expanding the pool of repair cells available after training-induced microtrauma. Research has also demonstrated anti-apoptotic effects in cardiac myocytes, bone defect healing via osteoblast proliferation (1.4x greater effect than IGF-1 in one study), and cartilage protection. Because PEGylation distributes the peptide systemically rather than locally, PEG-MGF can be injected subcutaneously rather than requiring intramuscular injection into specific muscle groups. Commonly studied alongside IGF1-LR3 in a complementary protocol: PEG-MGF post-workout for repair signaling, IGF1-LR3 on rest days for growth. For research and educational purposes only.

Commonly Studied With

These peptides are frequently researched alongside PEG-MGF: 2mg due to complementary mechanisms:

Category